SUMMARY The iron state was examined in two groups of pregnant women who were carriers of a and P thalassaemia genes. In both groups the haematological expression of the disease-namely, haemoglobin and mean cell haemoglobin concentrations-was nearly identical. In patients with a thalassaemia the ferritin concentrations and percentage of ferritin deficiency was the same as in normal pregnant patients, whereas in those with ,B thalassaemia the ferritin concentrations were usually much higher and iron deficiency four times less common. This variance appears to be explained by different degrees of extravascular or intravasular haemolysis between the two thalassaemias as assessed by the activities of serum a hydroxybutyrate dehydrogenase.
In 1984 Pardini et al reported that in patients with a thalassaemia concentrations of ferritin were similar to those of normal subjects, and were significantly lower than those associated with / thalassaemia, but no explanation was given.' We made a similar observation indirectly during a larger study on the haematological changes in pregnancy in over 2000 mixed ethnic patients with the thalassaemia trait (a and ,B).2 By 36 weeks' gestation patients with a thalassaemia showed the same incidence of iron deficiency as normal mothers (15-20%), but in those with ,B thalassaemia iron deficiency was uncommon (4%). Moreover, the difference in routine ferritin concentrations between the two became so obvious that the association of thalassaemic indices and a "high" ferritin concentration (>40ng/100ml) was almost diagnostic of ,B thalassaemia, but if the concentration was normal or low (<15 ng/100 ml) a thalassaemia was suspected. We had not, however, taken into account any differences in the cellular expression betweeen the two thalassaemias-namely, haemoglobin concentrations and mean cell haemoglobin values-or made allowance for the differences in age or parity.
We therefore re-examined the problem in two selected groups of patients in which these factors, especially haematological expression, were comparable or identical. At the same time the degree of extravascular and intravascular haemolysis was assessed by measuring the concentrations of serum a hydroxybutyrate dehydrogenase.
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The subjects were peninsular Arab women (from Yemen, United Arab Emirates, and Oman) who were carriers of either a (No 42) or ( (No 23) thalassaemia and in the 36-40 week of pregnancy. All were para II + I and between the ages of 20 and 25 years. They were receiving normal antenatal care with supplements of iron (100mg three times daily) and folate. The timing of pregnancy was chosen to provide the period of highest incidence of iron deficiency. The number of pregnancies and age of each patient was included to provide some equivalence of iron loss (years of menstruation plus three pregnancies).
A control group of Arabic women over 36 weeks' pregnant who had normal haemoglobin concentrations for the period of gestation, a normal mean cell haemoglobin value, and no other clinical complications was also studied.
The routine haematological variables were measured on a Coulter model S. The performance of the laboratory was monitored monthly by the NEQAS United Kingdom quality assurance programme, and in 1983-84 the deviation index was 0-5 (good). Haemoglobin A2 concentrations were measured by polydexide chromatography (normal range (SEM) 1-8-3-2% (0-15%)).3 Serum ferritin concentrations were measured by radioimmunoassay using commercial kits (Amersham UK). Serum a-hydroxybutyrate dehydrogenase was measured with the Boehringher commercial kit.
DIAGNOSIS OF a AND /3 THALASSAEMIA The diagnosis of a and / thalassaemia was made using the criteria described previously2-namely, the patients were screened by discriminant Iron state in a and ,B thalassaemia trait (0-9) *-I (P function analysis of the haematological variables using the formula: (mean cell volume -red cell count -(5 x haemoglobin concentration -34)),4 and if the function indicated a thalassaemic pattern they were divided into a and 1 thalassaemia by measuring the HbA2 concentrations. We were aware of the danger of making a diagnosis of a thalassaemia without biosynthetic data. The validity of this selection procedure has, however, been supported by DNA analysis of the a globin gene complex of seven patients with mean cell haemoglobin values of between 18 and 25 pg, selected by discriminant function analysis.5 Five of these patients were homozygous for the 3-7 deletion and two were heterozygous (Table 1) . Once the patient was diagnosed as a carrier of thalassaemia the serum ferritin concentration and a hydroxybutyrate dehydrogenase activity were measured on fresh repeat samples by an independent observer. Table 2 gives the range and the geometric means of the haematological variables of the two groups of patients studied compared with those of normal patients. There was little difference in the haematological expression of the thalassaemias with the exception of the mean cell haemoglobin value, which although marginally lower in the I thalassaemia group, was still not significant. Fig. 1 shows the geometric means and ranges of the serum ferritin concentration associated with the two groups of patients with thalassaemia and the normal group. There was no difference between the mean (SEM) concentration associated with # thalassaemia (14-1 (3-8) ng/ml) and normal (13 6 (3-2) ng/ml), but the mean value associated with the # thalassaemia group was much higher (42-8 (6 4) ng/ml). In addition, whereas the incidence of iron deficiency ferritin (<10 ng/ml) in the a thalassaemia group (16%) was roughly the same as that found in the normal pregnant group (14%), it was only 3% in the f thalassaemia group. patients with a thalassaemia and normal patients was 0-15, but between those with fi thalassaemia and normal patients 0-001, and between those with I thalassaemia and a thalassaemia 0-01.
Results

SERUM HYDROXYBUTYRATE DEHYDROGENASE ACTIVITIES
Discussion
These data confirm early findings2 that there is a noticeable difference in ferritin concentrations, and presumably iron state, between carriers of a thalassaemia and P thalassaemia and support the findings of Pardini et al.1 The problem is simply illustrated in Fig. 3 , which is taken from data from our earlier study.2 This compares the number of patients diagnosed as having a or ,B thalassaemia in early pregnancy, at which stage they had normal ferritin concentrations, with the number of those who subsequently became deficient in iron during the course of pregnancy. The development of iron deficiency was largely confined to the a thalassaemia group, To determine the cause for this variance we attempted in this present study to eliminate possible and obvious factors-namely, gestational variation, ethnic variation, and differences in cellular expression between the thalassaemias. With regard to the Iron state in a and ,B thalassaemia trait difference in cellular expression, although our groups were comparable, they were not exactly the same as it was difficult to find large numbers of patients with a thalassaemia with mean cell haemoglobin values of 18-22 pg. Nevertheless, although accepting that ,B thalassaemia is marginally more severe than a thalassaemia, the difference is not likely to explain the noticeable difference in the ferritin concentrations. We suggest, therefore, that the difference in iron state reflects the different degrees of dyserythropoiesis or intravascular haemolysis. We are aware that the a hydroxybutyrate dehydrogenase activity is only a guide to intravascular haemolysis and suggest that the study should be repeated using a more sensitive marker. It is, however, a simple and readily available test and indicates that alterations in the activities of a hydroxybutyrate dehydrogenase may in individual patients be of value in monitoring changes in the disease.
Finally, the common, or rather "normal," incidence of iron deficiency in women with a thalassaemia might result in confusion as to the correct diagnosis. Alternatively, once a patient has been diagnosed as having a thalassaemia, especially women, it must be assumed that they will develop iron deficiency at the 259 same rate as normal patients. Unfortunately, hypochromia will not be a guide.
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